The present paper analyses the results of competitive blood-cell repopulation experiments in which Cx43-WT (connexin 43 wild-type) host mice, whose own HSCs (haemopoietic stem cells) were deleted, were grafted with fetal liver cells: 50 % Gpi-1a (glucose phosphate isomerase-1a)/Cx43-WT cells competing with 50 % Gpi-1b/Cx43-WT, 50 % Gpi-1b/Cx43-HZ (heterozygous) or 50 % Gpi-1b/Cx43-KO (knock-out) cells. The percentages of platelets, granulocytes, red cells, B-cells and T-cells containing Gpi-1b in blood samples obtained from 22 to 186 days after grafting, and the percentages of high-proliferation-potential colony-forming cells containing Gpi-1b at 255 days after grafting, were measured. The results show that, if we wait 4 months so that we measure the percentages of Gpi-1b end-cells formed by initially resting stem cells in the graft, values in HZ mice are greater than those in WT and KO mice by 10 % or more. We propose a bipolar influence model for blood formation by grafted HSCs to explain this difference and other features of the data. Influence A is a direct one: for individual HSCs, the combined effect on HSC niching and HSC proliferation of Cx43 is superior to that of the KO allele. Influence B is a demographic one: HZ foundation mice compensate by having more HSCs than WT mice. The net outcome of influences A and B is that HZ is the winner.
INTRODUCTION
Do Cx43 (connexin 43) gap junctions on HSCs (haemopoietic stem cells) have a major role in blood formation? On abutting cells, the transmembrane proteins (connexins) of gap junctions form channels that allow the passage of ions, second messengers and molecules smaller than approx. 1 kDa. The multigene family of connexins is thoroughly reviewed in [1] . Cx43 is the major connexin in haemopoietic tissue, but others have been found: Cx37 in bone and in arteriolar epithelium, and Cx45 and Cx31 in marrow stromal cells [2] [3] [4] . Cx43 gap junctions are found between certain stromal cells in marrow [4] , but it is undecided whether haemopoietic cells express gap junctions. This uncertainty is because of the difficulty of identifying, with confidence and in the same experiment, both the type of blood cell(s) and a gap junction on a haemopoietic cell [5] [6] [7] . Three observations indicate that gap junctions on stromal cells couple those cells to haemopoietic cells: (i) when impermeant Lucifer Yellow dye [8] is injected into one stromal cell in fetal liver, many adjacent haemopoietic cells become dye-coupled [4] ; (ii) using confocal microscopy, the processes of stromal cells can be seen wrapping smaller rounded cells (which resemble primitive haemopoietic cells); (iii) using transmission or freeze-fracture electron microsopy [7] , we can see gap junctions between stromal and presumptive haemopoietic cells. In dayto-day blood formation, gap junctions are rare [4] , but there are more of them in the neonate, which is actively founding its blood-forming system, especially at the epiphysis and metaphysis (active sites of blood formation). There are even more gap junctions in irradiated mice or in those recovering their blood-forming system after cytoablation [7] . Gap-junctional haemopoietic communication is detectable in culture by injecting Lucifer Yellow into stromal cells (whence it spreads to identified haemopoietic cells [4] ). When we compare different lines of stromal cells, the more they are coupled to neighbouring cells the better they support the growth of long-term haemopoietic repopulating cells [9, 10] . Moreover, when the conductivity of gap junctions in long-term cultures is reduced to 2-3 % of normal by amphotericin B (2.5-5.0 nM), clonal blood formation is also blocked; this inhibition is entirely reversed by removal of the inhibitor [9] .
What is the function of gap junctions between stromal cells and HSCs? The simplest hypothesis is that they are another means, in addition to growth factors, by which to get resting HSCs into cycle [9, 11] . Mice that are homozygous for the Cx43 KO (knock-out) allele die at birth [12] . However, grafts of fetal liver stem cells of the three Cx43 genotypes can be compared in the live WT (wild-type) animal. Here we have used longterm (more than 4 months) competitive repopulation [13] to investigate whether there are differences in the repopulation efficiency of the three genotypes. We use a period of 4 months to ensure that we are comparing the repopulation efficiency of stem cells that are initially at rest in the graft (by 4 months, other haemopoietic cells have flourished and their progeny have effectively gone).
MATERIALS AND METHODS

Foundation mice
C57Bl/6J (B6) mice were used in these experiments: either normal B6 mice carrying the Gpi-1b (glucose phosphate isomerase-1b) marker allele or congenic Gpi-1a mice. Foundation animals were bought from Jackson Laboratories (Bar Harbor, MN, U.S.A.). The Gpi-1b foundation mice had the Cx43 KO allele bred on to a normal B6 background [5] .
All animal work was conducted according to the provisions of the 1986 Animals (Scientific Experimentation) Act, U.K.
Grafting material
We extracted the livers from 15-days post coitum embryos which were then genotyped. For each liver, a single- cell suspension was made in 90 % (v/v) fetal calf serum (Labtech) and 10 % dried (using molecular sieves; Sigma) DMSO (Sigma), and stored in liquid nitrogen (standard freezing procedures). For each experiment and 'donor' genotype, we thawed 12 or more livers into a single pool, one for each of the three combinations: Gpi-1b/ Cx43-WT, Gpi-1b/Cx43-HZ (heterozygous) and Gpi1b/Cx43-KO [14] . For the 'host' genotype Gpi-1a/ Cx43-WT, at least 36 livers were thawed and pooled.
Competitive repopulation
To compare the three Gpi-1b/Cx43 genotypes, we 'raced' each of them in Gpi-1a/Cx43-WT hosts against host Gpi-1a/Cx43-WT cells [13] . The hosts' HSCs had been deleted using 150 mg/kg busulphan (Sigma), but their Cx43-WT stromal cells were intact [14] . Each host was grafted with one fetal liver's worth of host cells and one fetal liver's worth of donor cells; we counted nucleated cells to confirm equal numbers of each type (of which a very small unknown proportion are HSCs).
Experimental design
The pooling of livers in each experiment was designed to obviate the influence of random variation. Measurements were made on 131 mice. Table 1 gives the numbers of mice in the different experimental categories for which we present and analyse results. Five mice were excluded: one dKO and one dWT mouse in experiment II did not survive to day 186; one dHZ mouse in experiment II failed its first bleed; and one dHZ and one dWT mouse in experiment III did not survive to day 57. Their exclusion simplifies the analyses without materially affecting the inferences that we draw from them. In blood samples obtained between 22 and 186 days after grafting, we measured for each mouse %b (the percentage of type Gpi-1b cells) in platelets, granulocytes, red cells, B-cells and T-cells [14] . These cell types range from the short-lived (hours for platelets, < 5 days for granulocytes and 50 days for red cells) to the longlived (months for B-cells; as much as 1 year for T-cells). In experiment II, we also measured in mice surviving to 255 days the percentage of type Gpi-1b HPP-CFCs (high-proliferation-potential colony-forming cells) [15] as the proportion of the colonies that were not of mixed type. In experiment II, mice were treated with FU (5-fluorouracil), as in [16] , 29 days before the second bleed; in experiment III, FU treatment was given 14 days before the second bleed. (FU deletes cells in cycle.)
Each experiment had three subexperiments corresponding to the three donor genotypes. The symbol dKO will, according to context, stand for both the donor genotype Gpi-1b/Cx43-KO and the subexperiment in which that genotype is raced against host Gpi-1a/Cx43-WT (likewise for dHZ and dWT).
To explore more fully the long-term (> 120 days) consequences of competitive repopulation, the bleeding at 131 days in experiment I was extended to 186 days in experiment II. The other three experiments, with bleeds at different stages under 100 days, were designed to provide a link between the long-term results and previous short-term studies. In each experiment, aliquots were taken from the same four pools of blood (for dWT, dHZ, dKO and host WT) and were handled using standard techniques of competitive repopulation experiments [13, [17] [18] [19] . The host mice in each experiment were 3 months old and of the same sex, and were randomly assigned to the three subexperiments.
Statistical methods
This paper can be read in two ways. Readers may skip statistical detail and commentary, and go directly from an appreciation of Figures 1 and 2 to the explanatory modelling of the Discussion. Readers who continue here will be able to judge for themselves the reliability of the basic data.
We have fitted merely descriptive linear models to the data of each experiment with corresponding ANOVAs in order (i) to quantify the relative contributions of different factors to the variation in the observed %b, (ii) to reveal the satisfactory behaviour of the (crossvalidatory) residuals and the consistency of six estimates of the S.D. of within-mouse experimental error, and (iii) to use significance tests as pointers to where explanatory modelling may be justifiably attempted. Table 2 employs a novel format for ANOVA tables that is both succinct and fully informative, using RMS (square roots of the usual mean squares) values which are on the same percentage scale as %b. There are two levels of random variation in the experiments. For comparisons of the three genotypes in each experiment, we have used, as the error term for F-tests, the 'between-mice' one in the second line of the ANOVA tables, with mice (but not cell pools) treated as the source of randomness. The estimates of genotype means include any component of random variation (from that between thawed livers) that is not eliminated by the pooling. For comparisons involving cell type or day, mice are treated as 'blocks' (in the terminology of Fisherian experimental design [20] ): such comparisons are unaffected by any single 'error' contributing additively to all the %b values of a mouse or of a subexperiment, and the appropriate error term is the 'within-mice' one (bottom line of the ANOVA tables). We have used so-called 'deleted residuals' [21] (better described as 'standardized cross-validatory residuals' in the spirit of [22] -scv-residuals for short) to check for data homogeneity in the fitting of each ANOVA's descriptive formula. Our statistical method is to consider the overall shape of the results, as expressed by simple descriptive formulae that do not, in themselves, make any theoretical assumption, rather than to make a large number of unintegrated local comparisons by conventional two-sample tests of significance and confidence intervals. Figure 1 shows how the means of %b values (averages over replicate mice whose numbers are given in Table 1) varied with genotype and cell type, in both long-term and short-term experiments. Figure 2 plots the average of the %b values for the short-lived platelets and granulocytes. The connecting lines show that the change over time is very different for the three genotypes. For day 255, the means are those of the HPP-CFC %b values. The unconnected points are for bleeds performed either after FU treatment or on day 131. Day 130 is used for the connection, so that the falls in %b to day 255 are 'within-mouse' comparisons.
RESULTS
Experiment I (131 days)
The formula fitted in ANOVA I (Table 2) has an additive structure for the %b value of a particular mouse and cell type: %b = (genotype mean) + (variation dependent on genotype and cell type) + (random variation for the mouse) + (random error)
where '(genotype mean)' is defined to give equal weight to cell types. (One mouse has been omitted from this analysis because a preliminary ANOVA gave it two large scv-residuals of opposite signs: + 4.7 for red cells and − 2.8 for T-cells.)
The differences between the three genotype means (in this experiment) are highly statistically significant compared with differences between mice within genotypes. Differences between cell types are also significant compared with the residual RMS of 3.5 %, which estimates both experimental error and deviations from the fitted
Figure 1 Mean percentage of donor cells in the five compartments [platelets (p), granulocytes (g), red cells (r), B-cells (B) and T-cells (T)] for donor genotypes dWT (+), dHZ ( × ) and dKO (᭺)
I-V denote the various experiments.
additive formula. The non-significant G × C interaction (see Table 2 ) reflects the parallelism of the three curves in Figure 1 
Experiment II (130, 186 and 255 days)
In addition to unconstrained dependence on genotype, cell type and day, the analytical technique allows mouse variation to depend additively on cell type and day. Therefore the fitted formula can now have a richer structure: %b = (genotype mean) + (variation dependent on genotype, cell type and day) + (random variation for the mouse, varying with cell type but the same for each day) + (random variation for the mouse, varying with day but the same for each cell type) + (random error)
This is the formula fitted in ANOVA II ( The unconnected points are for bleeds made after FU treatment or on day 131.
less 'noisy'. The ANOVA now gives a smaller residual RMS of 2.6 %. The lower noise level reveals the highly significant G × D interaction (P = 0.001) (see Table 2 ), which expresses the inequality of the changes from day 130 to day 186 in Table 3 .
Table 2 Six concisely represented ANOVAs
The entries in the table are RMS, superscripted degrees of freedom (df ), and (if stated) the F test P value (in parentheses) (*0 denotes P 0.0005). The symbol G stands for donor genotype (dWT, dHZ or dKO), M stands for mice within genotypes, C stands for cell type, and D stands for days (130 and 186 for expt II; 22 and 57 for expt III 2 ; and 22, 57 and 93 for expt III 3 ). Interpretation of two entries that use appropriately different error terms: the P value for G in expt I is the probability (< 0.0005) that an F-test statistic with 2 and 17 degrees of freedom exceeds 42 2 /8.8 2 = 23; the P value for C is the probability (also < 0.0005) that an F value with 4 and 68 degrees of freedom exceeds 14 2 /3.5 2 = 16. The residual RMS values in the bottom row (varying from 3.1 % to 3.8 %) are independent estimates of the S.D. of the 'error' in the measurement of %b -the part that is unaccounted for by experimental factors C, G, M and D when their effects are represented in the fitted formulae. The consistency of the estimates is evidence that laboratory procedures remained in 'statistical control' over the whole period of experimentation.
RMS
df (P) 
Experiment III (22, 57 and 93 days)
We analysed separately the III 3 mice bled on days 22, 57 and 93, and the 14 III 2 mice bled on days 22 and 57 that did not survive to day 93. The profusion of significant P values in ANOVAs III 3 and II 2 indicates that the mean %b values have a complex dependence on genotype, cell type and day (which we will not attempt to explore). However, the highly significant M × D interaction in ANOVA III 2 is more than noteworthy. It means that, once we have adjusted for the dependence on G, C and D (see Table 2 ), there are significant differences between mice in the change (up or down) between their %b values for days 22 and 57. Things are simpler and clearer (as in experiment II) if we focus on the average of the two %b values for platelets and granulocytes. For this datum, the fitting eqn (2) simplifies to: %b = (genotype mean) + (variation dependent on genotype and day) + (random variation for the mouse dependent on day) For each mouse and day, we can estimate the third term on the right of this 'model' -'random variation for the mouse dependent on day' (we shall call it RVM). Mice jump from being either above or below the mean for the genotype on day 22 to being either above or below on day 57. With a S.D. of 5.3 %, these changes (RVM at day 57 minus RVM at day 22) have a variability that is significantly greater than what even the residual RMS of 3.2 % in ANOVA III 2 (for all cell types) would countenance. However, this extra variability comes only with the post-FU day 57 values: the S.D.s of RVM are 1.3 % at day 22 and 5.2 % at day 57, a difference that does not depend significantly on genotype. We suggest that this feature of our data may reflect a post-FU decrease in the numbers of HSCs when they are distinguished by their type Gpi-1 marker -a decrease that is perhaps associated with the fact that these mice did not survive to day 93 (see end of Discussion).
Experiment IV (57 days)
The genotype means in Figure 1 (IV) present a complex picture, very different from the day 57 results in experiment III post-FU. The ranking of genotypes now depends on cell type, with highly variable arithmetical differences whose statistical significance is documented in ANOVA IV of Table 2 .
Experiment V (36 days)
In comparison with experiment IV, the means have a more lawful character. Despite the statistically significant G × C interaction, the ranking of genotypes is the same for all cell types, with dWT well in the lead.
Overall assessment
Unless we incorporate random subexperimental variation into our analyses of the genotype differences in experiments I and II, we have no explanation other than chance variation for the statistically significant reversal of the ranking of dKO and dWT mice between days 130 and 131 (with no allowance for selection of this feature, P < 0.0005). To have included subexperimental error, using the two or three degrees of freedom between experiments I and II (treated as replicates) for its estimation, would have complicated the presentation of the results.
(Designed replication of pools within experiments would have been informative.) For inference about genotype differences, we need to supplement the purely statistical analyses with a more subjective assessment and interpretation of the changes with time shown in Figure 2 .
For the within-mice comparisons involving cell type (C) or day (D), there is a reassuring consistency of the residual RMS values in the six ANOVAS of Table 2 (with an acceptable distribution of scv-residuals in all the ANOVAS). The range of findings in the five experiments can be crudely summarized as: (i) first-order genotype differences whose long-term character revealed in experiments I and II contrasts with the 'mixed bag' of differences in the short-term experiments; (ii) secondorder differences between cell types in experiments I, II, and V (contrasting with bigger differences in experiments III and IV); and (iii) third-order differences, such as the interaction of genotype with day in experiment II.
DISCUSSION (AND EXPLANATORY MODELLING)
The 'mixed bag' of short-term results
The observations of the short-term repopulations in experiments III, IV and V were paradoxical. This is likely to be due to a peculiarity of the deletion of blood-forming cells by busulphan: it deletes HSCs, but spares committed progenitors, which continue to form end-cells [14] . Thus enquiry while such progenitors are still in the race gives the impression of chaos, as the progenitors of first one genotype and then another form more end-cells. In the long-term study [14] , host progenitors were still forming lymphocytes on day 161, and the race was not over before day 202. For the present work we attempted to abbreviate the race by housing animals in open cages to allow them to encounter pathogens, but are uncertain how much this did so. There may be a slight residue of blood formation by grafted or host progenitors at day 130. Since FU deletes cells in cycle, the residual progenitors will be killed by it. Blood formation thereafter, especially of short-lived platelets and granulocytes, then reflects haemopoiesis by grafted HSCs.
Two features of the short-term results for platelets plus granulocytes in Figure 2 merit speculation: (a) the discrepancy between the results at day 57 in experiments III and IV (see end of the Appendix); and (b) the differences between genotypes in the changes between day 22 and day 36. 
Why does heterozygosity win the race for long-term repopulation?
Especially for platelets and granulocytes, the values of %b at 130, 131 and 186 days after grafting should be determined almost entirely by the daughter clones of grafted HSCs, and not influenced appreciably by progenitors in the host at the time of grafting. Rosendaal and Jopling [23] have presented the same data, and reported no consistent difference betweeen dWT and dKO genotypes. However, the most remarkable and unexpected feature of the data is the competitive advantage of the HZ graft in the the long-term subexperiments -'unexpected' because, for single-influence (unipolar) biological processes, an effect of heterozygosity is usually intermediate between those of the WT and KO genotypes. However, this ranking of genotypes need not hold for bipolar or multipolar phenomena, in which the allele has two or more pathways of influence on the final measurement. The simple play with numbers in Table 4 makes the point with total clarity. In our bipolar model to explain the genotype differences in the end-cells stemming from grafted HSCs, influence A is taken to be a direct one -that, on an individual cell basis, a grafted dHZ HSC makes a stochastically smaller contribution to the end-cell compartment at any particular time than does a grafted dWT HSC, while a grafted dKO HSC makes an even smaller contribution. (A contribution is stochastically smaller if, for any given contribution level, the probability of exceeding that level is smaller.) Influence A expresses the supposition that, for an individual HSC, the presence of Cx43 is better for making the connections in the stroma that assist haemopoiesis than its absence (the KO allele). For influence B, we then suppose that, because of influence A, a WT mouse does not need to maintain as many HSCs as an HZ mouse, which in turn does not have as many (in its fetal liver) as a KO fetus. In other words, HZ mice must have more HSCs than WT mice -an inequality presumably doubly inherited by the KO fetus. Influence B is then an indirect demographic one -the greater number of HSCs in HZ compared with WT mice more than makes up for their lower productivity, whereas the greater number in KO than in HZ animals are not enough to 'win out' over HZ. The model would be tested by any reliable method of counting the kind of HSC that we believe to be responsible for long-term repopulation.
Table 4 Hypothetical illustration of a bipolar influence
The numbers are the notional combined effects of the two independent influences that, by their sum, constitute some notional measurement. We do not accept that techniques such as those described in [24] can do this.
Another marker might help to test the model
All the raw data for this work are available in [25] (www. ucl.ac.uk/stats/research). None of it, however, is informative about the absolute numbers of HSCs that participate in our experiments -and that play a central role in our demographic model. At best, a %b value tells us about relative numbers, and then only with an assumption that HSC clone size is independent of genotype. To obtain data about absolute numbers, we would consider making use of a developmentally neutral, random binomial marker of the sort used by Harrison et al. [19] and studied theoretically by Stone [26] . The Gpi-1 marker (a/b) itself is completely confounded with the Cx genotype, which our results have shown to be influential (not 'neutral') in the development of the corresponding clones. This implies that the a/b marker cannot do the job. To obtain data that might be richly informative about the 'number' of HSCs of each competing genotype (strictly speaking, about the reciprocal of a carefully defined probability π ), it will be necessary to make use of a separate neutral marker, α/β say. For each subexperiment, there would then be four categories of distinguishably marked cells: a\α, a\β, b\α and b\β. The complementary information alluded to would be extractable from the variances and covariances of the percentages of a\β end-cells among those of type a, and of b\β end-cells among those of type b.
Conclusion
Our results suggest and support a bipolar model for the direct and demographic influences of the Cx43 gene on the efficiency of HSC transplantation. Whether or not the model can be validated by further studies, the findings may be of value to the understanding of a range of haemopoietic disorders.
APPENDIX
Tentative explanation of the G × D interaction in Table 3 Without refinement, the bipolar model does not explain the third-order effects for G × D in Table 3 , since it does not deal with any question of systematic temporal change, such as an interaction of genotype and day. We offer the following tentative refinement. The results for experiment II as a whole, which include the %b values for HPP-CFCs at day 255, suggest that we may be dealing with a combination of (a) a progressive change in the long-term balance between donor and host HSCs (favouring the latter), and (b) a temporary blip associated with FU treatment at day 157 (i.e. day 186 minus 29). The progressive change is a decline in the proliferative ability of just the donor HSCs, affecting all three genotypes, showing up as the overall decrease of 12 % between day 186 and day 255. It also shows as the 3.5 % decrease in dWT in Table 3 between day 130 and day 186. However, a change that affected donor HSCs (as such) would not explain the G × D interaction in Table 3 , which says that, although dWT lost 3.5 %, dKO gained 2.3 % and dHZ lost an intermediate 2.1 %. For this, we invoke a temporary blip that favours dKO over dHZ (and dHZ over dWT), and suggest that it may be a repeat performance of the model's influence B: the numerous dKO HSCs dominate a temporary response to FU treatment (one that is less dependent on Cx43 connections). For a time, dKO plays the major role in meeting the urgent temporary need for proliferation (with the less numerous dHZ HSCs as 'runners up'). A similar argument involving influence B might explain the discrepancy between the results at day 57 in experiments III and IV: the differences between 'with FU' and 'without FU' parallel the changes between day 186 (after FU) and day 130 (before FU) in Table 3 .
